Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705601 · ClinicalTrials.gov registry record
Nonrestorative Sleep RSQ (Restorative Sleep Questionnaire) Development-- Methodology Study
A clinical trial, sponsored by Pfizer.
- Terminated
- Registry status
- 64
- Enrollment target
NCT00705601 is a clinical trial that was terminated before completion, run by Pfizer. The registered enrollment target is 64 participants.
The verdict
NCT00705601 was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- 64 participants
- Enrollment target
Study Summary
To begin to refine development of the RSQ (Restorative Sleep Questionnaire) measure in subjects with NRS (Nonrestorative Sleep) by generating item content pertaining to morning refreshment and uncovering problems in instrument administration in subjects with nonrestorative sleep
Interventions
- PROCEDURE PSG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00705601
The ClinicalTrials.gov registry entry for NCT00705601 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PSG is the first listed.
NCT00705601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00705601 about?
NCT00705601 is a clinical study titled "Nonrestorative Sleep RSQ (Restorative Sleep Questionnaire) Development-- Methodology Study". To begin to refine development of the RSQ (Restorative Sleep Questionnaire) measure in subjects with NRS (Nonrestorative Sleep) by generating item content pertaining to morning refreshment and uncovering problems in instrument administration in subjects with nonrestorative sleep
What is the current status of trial NCT00705601?
This trial is currently terminated. The enrollment target is 64 participants. The study started on 2008-08. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00705601?
The interventions under investigation include: PSG (PROCEDURE).
Who is sponsoring clinical trial NCT00705601?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.